ConductScience.org, home

Paper40868936

Intersecting Pathways of Inflammation, Oxidative Stress, and Atherogenesis in the Evaluation of CKD: Emerging Biomarkers PCSK9, EPHX2, AOPPs, and TBARSs.

Assani MZ and 6 others. Life (Basel), 2025. Cited by 4 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Intersecting Pathways of Inflammation, Oxidative Stress, and Atherogenesis in the Evaluation of CKD: Emerging Biomarkers PCSK9, EPHX2, AOPPs, and TBARSs. Papers, record 40868936. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40868936

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intersecting Pathways of Inflammation, Oxidative Stress, and Atherogenesis in the Evaluation of CKD: Emerging Biomarkers PCSK9, EPHX2, AOPPs, and TBARSs.
PubMed
Journal
Life (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-09-14
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Assani MZMohamed-Zakariahttps://orcid.org/0009-0009-3146-8769
2Novac MBMarius Bogdan
3Dijmărescu ALAnda Lorena
4Stroe-Ionescu AȘAlexandra-Ștefania
5Boldeanu MVMihail Virgilhttps://orcid.org/0000-0003-2481-6138
6Siloși IIsabela
7Boldeanu LLidiahttps://orcid.org/0000-0002-4817-1365

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References227

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127,222,740Oxidative stress during erythropoietin hyporesponsiveness anemia at end stage renal disease: Molecular and biochemical studies.J Adv Res2016https://conductscience.org/library/papers/27222740PubMed
223,046,363Targeting the AGE-RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end-product content.Nephrology (Carlton)2013https://conductscience.org/library/papers/23046363PubMed
323,431,388A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease.PLoS One2013https://conductscience.org/library/papers/23431388PubMed
439,682,569Correlation Between Prognostic Nutritional Index, Glasgow Prognostic Score, and Different Obesity-Related Indices in People with Diabetes or Prediabetes.Diagnostics (Basel)2024https://conductscience.org/library/papers/39682569PubMed
530,934,586Measurement and Clinical Significance of Lipid Peroxidation as a Biomarker of Oxidative Stress: Oxidative Stress in Diabetes, Atherosclerosis, and Chronic Inflammation.Antioxidants (Basel)2019https://conductscience.org/library/papers/30934586PubMed
627,562,094TNF-α induces vascular insulin resistance via positive modulation of PTEN and decreased Akt/eNOS/NO signaling in high fat diet-fed mice.Cardiovasc Diabetol2016https://conductscience.org/library/papers/27562094PubMed
723,761,459The Nrf2 pathway in the progression of renal disease.Nephrol Dial Transplant2014https://conductscience.org/library/papers/23761459PubMed
834,356,387Oxidative Stress in Patients with Advanced CKD and Renal Replacement Therapy: The Key Role of Peripheral Blood Leukocytes.Antioxidants (Basel)2021https://conductscience.org/library/papers/34356387PubMed
928,804,094Lipid Lowering Therapy and Circulating PCSK9 Concentration.J Atheroscler Thromb2017https://conductscience.org/library/papers/28804094PubMed
1036,755,850Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019.Clin Kidney J2023https://conductscience.org/library/papers/36755850PubMed
1136,090,671Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study.Lancet Reg Health Eur2022https://conductscience.org/library/papers/36090671PubMed
1226,785,996Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review.Curr Med Chem2016https://conductscience.org/library/papers/26785996PubMed
1323,493,288The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors.Arterioscler Thromb Vasc Biol2013https://conductscience.org/library/papers/23493288PubMed
1440,244,241The Clinical Utility and Plausibility of Oxidative and Antioxidant Variables in Chronic and End-Stage Kidney Disease: A Review of the Literature.Int J Mol Sci2025https://conductscience.org/library/papers/40244241PubMed
1533,525,066Role of Inflammation in Arterial Calcification.Korean Circ J2021https://conductscience.org/library/papers/33525066PubMed
1638,448,299Association between CYP4A11 and EPHX2 genetic polymorphisms and chronic kidney disease progression in hypertensive patients.Nefrologia (Engl Ed)2024https://conductscience.org/library/papers/38448299PubMed
1739,430,292Therapy Targeted to the NLRP3 Inflammasome in Chronic Kidney Disease.Kidney Dis (Basel)2024https://conductscience.org/library/papers/39430292PubMed
1838,523,633Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition.Front Pharmacol2024https://conductscience.org/library/papers/38523633PubMed
1938,455,648Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases.Front Endocrinol (Lausanne)2024https://conductscience.org/library/papers/38455648PubMed
2037,053,275Endothelial Cell Dysfunction and Increased Cardiovascular Risk in Patients With Chronic Kidney Disease.Circ Res2023https://conductscience.org/library/papers/37053275PubMed

See all 227 references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42,921,216Shared Tissue-Level Molecular Signatures and Immunometabolic Associations in Nonalcoholic Steatohepatitis and Chronic Kidney Disease: Potential Endothelial Relevance.J Inflamm Res2026https://conductscience.org/library/papers/42921216PubMed
42,626,011Efficacy of finerenone in reducing proteinuria in diabetic kidney disease on dapagliflozin and telmisartan: A disease-modifying approach.World J Nephrol2026https://conductscience.org/library/papers/42626011PubMed
41,595,770Associations of Transforming Growth Factor-β (TGF-β) with Chronic Kidney Disease Progression in Patients Attending a Tertiary Hospital in Johannesburg, South Africa.Biomedicines2026https://conductscience.org/library/papers/41595770PubMed
41,465,784Beyond HOMA-IR: Comparative Evaluation of Insulin Resistance and Anthropometric Indices Across Prediabetes and Type 2 Diabetes Mellitus in Metabolic Syndrome Patients.Life (Basel)2025https://conductscience.org/library/papers/41465784PubMed
41,154,568Stress Pathways in Chronic Kidney Disease: Linking Cortisol, Oxidative Stress, and Inflammation.Antioxidants (Basel)2025https://conductscience.org/library/papers/41154568PubMed

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EPHX22,053PubTator's text mininghttps://conductscience.org/library/genes/2053NCBI Gene
PCSK9255,738PubTator's text mininghttps://conductscience.org/library/genes/255738NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40868936

GET https://conductscience.org/api/papers/v1/40868936/references?page=2